<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>D. Pettersson | Ruth Palmer Lab</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/d.-pettersson/</link><atom:link href="https://deploy-preview-3--ruthpalmerlab.netlify.app/author/d.-pettersson/index.xml" rel="self" type="application/rss+xml"/><description>D. Pettersson</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 30 May 2024 00:00:00 +0000</lastBuildDate><image><url>https://deploy-preview-3--ruthpalmerlab.netlify.app/media/icon_hua1ac8766117554d27209418f2eeeba33_52656_512x512_fill_lanczos_center_3.png</url><title>D. Pettersson</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/d.-pettersson/</link></image><item><title>Comparison of (177)Lu-octreotate and (177)Lu-octreotide for treatment in human neuroblastoma-bearing mice</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/lu_octreotide_comparison/</link><pubDate>Thu, 30 May 2024 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/lu_octreotide_comparison/</guid><description/></item></channel></rss>